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Objectives: To date the focus of both development and application of HRQoL instru-
ments has been on research/clinical trials, but their application in clinical practice has 
been neglected. Therefore a PRO was conceptualized for use in clinical practice. The 
aim of this study was to explore the views of patients with haematological malignan-
cies (HM) concerning the quality of life issues important to them. MethOds: Ethics 
approval was obtained from Bristol Ethics Committee. Adult patients (with myeloid 
or lymphoid neoplasm or acute leukemia according to 2008 WHO classification at any 
stage of disease) capable of reading/understanding English and able to give informed 
written consent were recruited into the study. This qualitative study employed semi-
structured interviews (face-to-face or by phone) and survey (online) with open-ended 
questions for data collection. Interviews were tape recorded and transcribed verba-
tim. Content analysis was carried out using Nvivo9. Results: 57 patients (male= 37; 
female= 20) with mean age of 61.8 (sd= 9.1) and mean duration of disease of 3.7 
(sd= 3.1) were recruited into the study. 14 of the 17 interviews were face-to-face and 
remaining 40 were online surveys. Of the 57, 46 were multiple myeloma, 8 MDS, one 
NHL and 2 AML. Issues reported by patients were grouped into two broad categories: 
symptoms; and QoL. The symptoms were grouped into 5 categories: breathlessness; 
fractures; spinal problems; anaemia and black urine. 21 QoL issues were reported by 
patients with the highly prevalent items being ‘feeling angry’, ‘avoid crowds’, ‘strain on 
relationships’, ‘unable to do any activity’ and ‘doing things slowly’. These QoL issues 
appear to be unique to such patients. cOnclusiOns: The findings of this study 
indicate that there are certain symptoms and QoL issues that are specific to patients 
with HM and thus deserve a dedicated recognition. This also demonstrates the depth 
and breadth of the impact of HM on physical and psychosocial functional behavior.
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Objectives: The current value set for the German version of the EQ-5D-3L was gen-
erated more than 10 years ago and there is also a demand for a new valuation study, 
because the questionnaire has been changed from a 3-level to a 5-level version. The 
aim of this study was to derive a value set for the EQ-5D-5L for Germany. MethOds: 
The study design followed, as one of the first countries, the improved EQ-5D-5L valu-
ation protocol developed by the EuroQol Research Foundation. Data were collected in 
computer assisted personal interviews with members of the German general popula-
tion. Participants were asked to each value a randomly selected block of 10 EQ-5D-5L 
health states using composite time trade-off (cTTO). Econometric modelling was used 
to estimate values for all 3,125 possible health states described by the EQ-5D-5L. The 
most appropriate model was determined in terms of logical consistency, goodness 
of fit and parsimony. Results: The values for 86 selected EQ-5D-5L health states 
were elicited using cTTO from a representative general population sample (n= 1,159). 
Random effects model with main effects represented by 20 dummy variables and a 
constant performed better than the other models. This model showed high consist-
ency in the sense that the higher the dimensional level the lower the coefficient for 
all parameter estimates (p-value< 0.05). The predicted values ranged from -0.4675 to 
0.9876. cOnclusiOns: The improved valuation protocol combined with intensive 
interviewer training and close data monitoring showed a high feasibility and accept-
ability to respondents as well as interviewers in Germany and resulted in high data 
quality. The EQ-5D-5L preference values estimated in this study might facilitate the 
use of the EQ-5D-5L in a range of applications like in cost-utility analysis for health 
care policy and clinical assessment in Germany.
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Objectives: ASCEND is a phase 3, randomized, double-blind, placebo-controlled 
trial designed to assess whether natalizumab slows disability progression in sec-
ondary progressive multiple sclerosis (SPMS). The objective of this study was to 
use Rasch Measurement Theory (RMT) methods to evaluate the Multiple Sclerosis 
Impact Scale (MSIS-29) and MS Walking Scale (MSWS-12), patient-reported out-
come instruments assessing the impact of MS, and to explore an optimized scor-
ing structure based on empirical post-hoc analyses. MethOds: Baseline blinded 
data from ASCEND (n= 889) were analyzed. In stage 1, RMT methods examined: 
scale-to-sample targeting, item fit, local dependency, and reliability. In stage 2, a 
post-hoc revision of the scoring structure (MSIS-29 and MSWS-12) and conceptual 
grouping of items (MSIS-29 only) was conducted and re-evaluated. Results: Stage 
1 showed adequate scale performance for the MSIS-29 except for item misfit (6 
Physical items; 2 Psychological items), suggesting more than two clinical concepts. 
The MSWS-12 performed psychometrically well except for disordered thresholds 
(2/12), item misfit (3/12) and mis-targeting (person location range: -5.01 to 5.77; item 
location range: -2.99 to 4.10). For stage 2, two MSWS-12 items were rescored. The 
revised MSWS-12 showed improved scale performance (i.e., response categories and 
item fit), but not targeting. The MSIS-29 was re-categorized into three conceptually 
clearer sub-scales: ‘Symptoms’; ‘Psychological’; ‘Limitations’. The revised MSIS-29 
scoring structure improved targeting and some item misfit (person location range; 
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Objectives: Existing evidence on the psychometric properties of physical func-
tioning and pain outcomes measures used in the chronic low back pain (CLBP) 
trials are not been systematically reviewed. The objective of our study was to 
evaluate the methodological quality of studies that evaluated psychometric prop-
erties of functioning and pain outcome measures for CLBP using Consensus-based 
Standards for the selection of health status Measurement Instruments (COSMIN) 
check list. MethOds: We searched Pubmed and EMBASE databases from inception 
to June 2015 with specific key words. Longitudinal cohort and cross sectional stud-
ies which included at least one assessment of psychometric property of outcomes 
measure in CLBP patients were included. Studies published in English language 
and on humans were included. Studies published as reviews, editorials and case 
reports were excluded. Two reviewers independently performed study selection, 
data extraction and quality assessment procedures; disagreements between 
reviewers were resolved through discussion. Results: A total of 32 studies met 
our inclusion criteria. In this systematic review only one third (34%) of instruments 
were tested for all psychometric properties and showed mixed methodological 
quality according to COSMIN check list. Among all instruments Quebec Back 
Pain Disability Scale had showed excellent reliability (Cronbach’s alpha coeffi-
cient 0.96) and test-retest reliability (ICC= 0.92) for physical functioning assess-
ment. Pain Catastrophising Scale had showed excellent reliability (α = 0.92) and 
high degree test-retest reliability (ICC= 0.842). More than half of the instruments 
showed excellent/good reliability and half showed fair validity. Responsiveness 
was assessed in only nine studies and had all showed fair quality. cOnclusiOns: 
Overall we found moderate methodological quality for most of the measures to 
advise tools use based on psychometric properties. Further research is needed to 
investigate the psychometric properties of all outcome measures used in CLBP 
research.
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Objectives: Although job-related stress has been reported to critically influence 
quality of life (QoL), few studies reported the optimum instruments to measure job-
related QoL. The aim of the study was to investigate the type and frequency of instru-
ment used to assesses the level of stress or quality of life related work. MethOds: A 
systemic search of PubMed was employed to find all relevant full texts for recent 5 
years focusing on human participants. Search keywords included “job-related stress 
or work-related stress”, and “Quality of life”. Information regarding the methods 
used to quantify stress, instruments used to measure quality of life, demographic 
and professional characteristics of the target population, as well as the sample size 
was gathered. Results: 50 studies were found during study period, of which 28 
of them examined the job related stress and the QoL. Of those 28 studies, health 
care workers were most frequently studied (19), and diverse methods were used 
to quantify the level of stress, of which JCQ (Karasek’s job content questionnaire), 
was most frequently used, followed by ERI(Siegrist’s Effort-Reward Imbalance) and 
JSS(Job Stress Scale). Frequently, however, stress level was not quantified at all 
(5 out of 28 studies). Regarding QoL instruments, SF-12/36 were most frequently 
used (11 studies), followed by PROQoL(The Professional Quality of Life Scale) and 
WHOQoL(The World Health Organization Quality of Life)., yet few studies provided 
explanation regarding the selection of the methods used. cOnclusiOns: Diverse 
methods have been used to evaluate the impact of job-related stress on the QoL, 
without proper justification. Methodologically robust studies could enhance the 
importance of job-related stress on the QoL.
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Objectives: To compare two methods for estimation of Work Limitations 
Questionnaire scores (WLQ, 8 items) from the Role Physical (RP, 4 items) and Role 
Emotional scales (RE, 3 items) of the SF-36 Health survey. These measures assess 
limitations in role performance attributed to health (emotional, physical, or both) 
and different breadth of impact (work vs. work and other activities). We compared 
WLQ estimates based on an item response theory crosswalk (Method1) and a regres-
sion imputation (Method 2). Such estimates can expand the information from 
studies using only the SF-36 measure, and can inform future data collection strate-
gies. MethOds: We used data from two independent cross-sectional panel samples 
(Sample1, n= 1382, 51% female, 72% Caucasian, 49% with preselected chronic condi-
tions, 15% with fair/poor health; Sample2, n= 301, 45% female, 90% Caucasian, 47% 
with preselected chronic conditions, 21% with fair/poor health). Method 1 used previ-
ously developed and validated IRT based calibration tables. Method 2 used regression 
models to develop aggregate imputation weights as described in the literature. We 
evaluated the agreement of observed and estimated WLQ scale scores from the two 
methods and their ability to discriminate among known groups of patients. Results: 
Estimated scores from the two methods were strongly correlated (r= .99). Estimated 
and observed scale scores had strong correlations (r= .68 for RE and r= .76 for RP). 
Observed and estimated WLQ from both methods successfully differentiated between 
levels of self reported general health and between patients with and without chronic 
conditions. For both methods the estimated WLQ means from SF36RP score were 
closer (and not statistically different for Method1) to the observed WLQ means than 
estimated WLQ scores from the SF36 RE scale. cOnclusiOns: Our results suggest 
that both methods provide useful WLQ estimates for group level analysis. Method 1 
appears slightly more accurate than Method 2, but is computationally more complex.
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Objectives: Asthma is one of the most common long term medical conditions 
and an important contributor to the burden of illness. People with asthma expe-
rience poor life satisfaction and require a range of health services to manage 
their condition. There is a need to assess the instruments by disease concept and 
interpret the dimension scores. The aim of this systematic review is to assess 
the impact of severe asthma on the quality of life (QoL). MethOds: A system-
atic search was conducted of the relevant published evidence from Embase and 
MEDLINE. Search limits were: articles in English, in human and published since 
year 2005. Retrieved citations were screened by two independent reviewers accord-
ing to inclusion criteria: severe asthma and baseline QoL data either measured 
on generic scale or disease-specific scale. Results: A total 29 studies met the 
inclusion criteria. The majority of studies were observational (14 studies) while 
seven studies had cross-sectional design. The majority of studies were conducted 
in adult population (18 studies) while few studies were conducted in children (5 
studies). Asthma Quality of Life Questionnaire (AQLQ) was the most frequently 
used scale among the included studies, assessed in 13 studies followed by St. 
George’s Respiratory Questionnaire (SGRQ) in six studies. Seven studies reported 
total AQLQ data with mean scores ranging from 3.1-4.8, which reflect poor QoL. 
Across these domains, scores assessed on AQLQ - symptoms and AQLQ - activity 
limitations were lower as compared to AQLQ - emotional function and AQLQ - 
environmental stimuli. Data also suggested that patients with severe asthma have 
rapid deterioration in overall health status as compared to patients with mild-
moderate asthma. cOnclusiOns: Patients with severe asthma had lower total 
QoL scores as assessed through different scales, indicating worse QoL. Symptoms 
and activity limitations are the two main domains that potentially affect the QoL 
in patients with severe asthma.
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Objectives: The objective of this study is to assess the translatability of “distressed” 
and to explore conceptually equivalent alternatives. The term has been observed to 
cause difficulties during translation of Clinical Outcomes Assessments (COAs), thus 
warranting further investigation. MethOds: Using Qualtrics, a web-based survey 
distribution service, a questionnaire was sent to 52 linguists who recently translated 
“distressed” in a questionnaire. They were asked if they faced difficulties in translat-
ing the term, to elaborate on these difficulties if applicable and provide conceptually 
equivalent alternatives. Additionally, cognitive debriefing results of “distressed” were 
analyzed. Results: Out of 52 linguists, 29 responded to the questionnaire. Sixty-
two percent (62%) of respondents (18 /29) stated that “distressed” was difficult to 
translate. Synonyms presented by all sample members show that “distressed” lacks 
conceptual equivalency across languages. The most common synonyms provided 
were “suffering,” “affliction,” and “sorrow,” showing variation in the way respondents 
interpret emotional pain associated with “distress.” Four respondents indicated 
that “distressed” could refer to physical or emotional pain in their language. Two 
respondents reported that their language had multiple terms which correspond 
to “distressed.” Nine languages were available for cognitive debriefing analysis. 
“Distressed” appeared to be problematic for four out of the nine languages. Although 
minimal issues were found with the term during debriefing, some subjects claim the 
term to be ambiguous or inappropriate for use in patient questionnaires, which is 
concordant with linguist feedback. cOnclusiOns: Results show that “distressed” 
can be difficult to translate, due to its ambiguity in describing adverse effects. When 
developing a source item measuring distress, it is recommended that multiple alter-
natives such as “despair,” “mental suffering,” and “anxiety” be measured in lieu of a 
single item on “distress,” as the suggested alternatives can neither be ambiguous nor 
misconstrued.
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Objectives: Health satisfaction may help predict adherence to T2DM self-care 
behaviors, a cornerstone of optimal T2DM management. The CHES-Q was developed 
to assess T2DM-related health satisfaction and knowledge among people living with 
T2DM. Because renal impairment is a frequent complication of T2DM, we aimed to 
better understand the experiences of people with T2DM and comorbid CKD and their 
interpretation of CHES-Q items. MethOds: In-depth interviews were conducted 
with 20 adults with T2DM and CKD (stages 1-5) to explore the content and clarity of 
the 14-item CHES-Q. Each interview included a brief discussion about the partici-
pant’s experiences and impact of T2DM and CKD. Then, participants were asked to 
“think out loud” about their process for answering each item and to identify words 
or concepts that were unclear. Probes were used to obtain additional feedback about 
whether any important concepts were missing. Interview responses were grouped 
and summarized. Results: The mean age of participants was 59 years, half were 
female, 45% were white, and 75% completed at least some college. Fifty-five percent 
had stage 5 CKD, 45% were on dialysis, and 2 had received a kidney transplant. 
Average disease duration was 15 years for T2DM and 7.7 years for CKD. All par-
ticipants found the instructions and items clear and relevant. Items that did not 
specifically refer to T2DM or blood sugar were interpreted by participants as relating 
to their health in general. Concepts reported as missing from the CHES-Q included 
erectile dysfunction, concern with diet, and stress, which were each mentioned by 
1 to 3 participants. cOnclusiOns: Health satisfaction is an important concept to 
consider when developing individualized strategies for managing T2DM because 
it may predict adherence to self-care. The CHES-Q assesses T2DM-related health 
satisfaction and is appropriate for use among people with T2DM and comorbid CKD.
item location range; number of items misfitting): ‘Symptoms’ (-4.75 to 4.56; -3.38 
to 2.17; 3/14); ‘Psychological’ (-4.20 to 4.27; -2.53 to 2.65; 1/5); ‘Limitations’ (-4.50 to 
4.55; -2.75 to 2.69; 3/10). cOnclusiOns: Findings from the post-hoc analyses of the 
proposed revised MSIS-29 and MSWS-12 provide an initial evidence-base for the 
enhancement of their measurement performance in patients with SPMS. Additional 
research is needed to determine the extent of improved scale-to-sample targeting 
and interpretability of the impact of MS.
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Objectives: To assess effects of CZP+MTX vs PBO+MTX on workplace and house-
hold productivity and need for help with daily activities in DMARD-naïve patients 
with severe, active, progressive RA.1 MethOds: Patients in this double-blind ran-
domized study (NCT01519791) were DMARD-naïve with active RA < 1yr diagnosis 
at baseline, fulfilling 2010 ACR/EULAR criteria; ≥ 4 swollen and ≥ 4 tender joints; 
DAS28[ESR]≥ 3.2; CRP≥ 10mg/L and/or ESR≥ 28mm/hr, RF/ACPA positive. Patients 
were randomized 3:1 to CZP (400mg Wks 0,2,4 then 200mg Q2W to Wk52)+MTX 
or PBO+MTX (MTX initiated at 10mg/wk, increased to 25mg/wk by Wk8, maxi-
mum tolerated dose maintained to Wk52). Workplace and household productiv-
ity (Work Productivity Survey [WPS]) were assessed; responses (LOCF imputation) 
compared using a non-parametric bootstrap-t method. Need for assistance was 
summarized descriptively. Results: 660 (CZP+MTX) and 219 (PBO+MTX) patients 
were randomized; 655 vs 213 in the full analysis set (pts with baseline and post-
baseline DAS28[ESR]). Baseline characteristics were balanced between study arms; 
52% employed. CZP+MTX patients reported greater improvements vs PBO+MTX 
in household productivity (household work days missed per month BL vs Wk52: 
PBO+MTX= 10.4 vs 3.0, CZP+MTX= 8.8 vs 1.9; household work days with productivity 
reduced by ≥ 50%/month: PBO+MTX= 10.6 vs 3.0, CZP+MTX= 9.4 vs 2.1; level of arthri-
tis interference with household work productivity/month: PBO+MTX= 6.4 vs 2.5, 
CZP+MTX= 6.0 vs 1.9). CZP+MTX patients also reported lower need for assistance in 
usual activities from a relative/friend. Employed CZP+MTX patients reported reduc-
tions in absenteeism and presenteeism vs PBO+MTX (work days missed/month BL 
vs Wk52: PBO+MTX= 4.0 vs 0.9, CZP+MTX= 4.4 vs 0.6; days with work productivity 
reduced by ≥ 50%/month: PBO+MTX= 8.8 vs 1.8, CZP+MTX= 6.4 vs 1.0; level of arthritis 
interference with work productivity/month: PBO+MTX= 5.8 vs 1.9, CZP+MTX= 5.5 vs 
1.4). cOnclusiOns: In DMARD-naïve patients with severe, active, progressive RA, 
CZP+MTX showed greater improvements at 1-year in workplace and household 
productivity and reduced need for assistance with regular activities vs PBO+MTX. 
1. Emery. Ann Rheum Dis 2015;74(S2):712
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Objectives: To identify common translation issues occurring during linguistic 
validation of depression scales; to assess possible solutions that could be applied 
across target languages. MethOds: We gathered back-translation reviews from 
linguistic validation projects comprising four depression scales and spanning 
thirteen languages; identified issues faced during discussion with lead linguis-
tic validation consultants in-country; compared problems and solutions to find 
any patterns; highlighted challenges common to depression scales. Results: 
There were three main challenges: 1. Colloquial expressions are frequently used. 
Problematic items included ‘I could not get going’ and ‘I could not shake off the 
blues’. All languages reviewed had no colloquial equivalent for ‘shake off the 
blues’; we resolved to create conceptual equivalence (‘I could not get rid of my 
depression’/’I could not stop feeling sad’) with a conversational register to reflect 
the source. 2. Some symptoms of depression are challenging to translate. For 
example, ‘worthless’ and ‘worthwhile’ posed problems for 62% of languages. Most 
often, the terms were confused with ‘useless/useful’. Where there was no direct 
translation, and when suitable for the clinical context, these terms were translated 
as ‘worth nothing’ and ‘valuable’. 3. The marginally-nuanced ideas were no prob-
lem for a broad English vocabulary, however, during linguistic validation, there was 
difficulty differentiating between English source terms such as ‘wound-up’, ‘nerv-
ous’, ‘agitated’, ‘restless’ and ‘tense’. All target languages struggled to translate 
‘nervous’ and ‘wound-up’ in two separate terms. Project managers defined the lat-
ter as ‘brought to a state of great tension’, possibly including ‘nervous movement’, 
and the concept was rendered successfully. cOnclusiOns: Attitudes towards 
depression vary across different cultures. Verbatim translations are found to be 
risky for numerous reasons but, with careful discussion between lead linguists and 
project managers, conceptually-equivalent, culturally-adapted wording is found 
to allow for this. To the issues reviewed, similar solutions were applied across 
languages and in different depression scales.
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